Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advancing Multiple Sclerosis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT04141891
What this trial is testing

Advancing Understanding of Transportation Options

Who this might be right for
Diabetic RetinopathyMacular DegenerationGlaucoma+29 more
University of Colorado, Denver 529
Not applicableStudy completedNCT02996084
What this trial is testing

MS PATHS Normative Sub-Study

Who this might be right for
Healthy Volunteer
Biogen 246
Large-scale testing (Phase 3)Study completedNCT03623243
What this trial is testing

Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients

Who this might be right for
Multiple SclerosisRelapsing Multiple SclerosisAdvancing Multiple Sclerosis
Novartis Pharmaceuticals 185
Not applicableStudy completedNCT04123353
What this trial is testing

Scan-Rescan Sub-Study of MS PATHS

Who this might be right for
Multiple Sclerosis
Biogen 30
Not applicableStudy completedNCT05058729
What this trial is testing

MS PATHS COVID-19 Questionnaire Data Linkage Sub-Study

Who this might be right for
Multiple Sclerosis (MS)
Biogen 1,507
Not applicableLooking for participantsNCT07037966
What this trial is testing

Advancing Portable Brain Imaging: The NextMRI Project's Role in Revolutionizing Diagnostic MRI

Who this might be right for
Multiple Sclerosis
Instituto de Investigacion Sanitaria La Fe 50